Annual CFF
$25.79 M
+$25.79 M+100.00%
December 31, 2023
Summary
- As of February 12, 2025, NVNO annual cash flow from financing activities is $25.79 million, with the most recent change of +$25.79 million (+100.00%) on December 31, 2023.
- During the last 3 years, NVNO annual CFF has risen by +$10.72 million (+71.09%).
- NVNO annual CFF is now -55.23% below its all-time high of $57.61 million, reached on December 31, 2021.
Performance
NVNO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$13.59 M
+$13.59 M+100.00%
September 30, 2024
Summary
- As of February 12, 2025, NVNO quarterly cash flow from financing activities is $13.59 million, with the most recent change of +$13.59 million (+100.00%) on September 30, 2024.
- Over the past year, NVNO quarterly CFF has dropped by -$12.20 million (-47.30%).
- NVNO quarterly CFF is now -64.58% below its all-time high of $38.37 million, reached on March 31, 2021.
Performance
NVNO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$39.43 M
+$13.59 M+52.60%
September 30, 2024
Summary
- As of February 12, 2025, NVNO TTM cash flow from financing activities is $39.43 million, with the most recent change of +$13.59 million (+52.60%) on September 30, 2024.
- Over the past year, NVNO TTM CFF has increased by +$13.64 million (+52.88%).
- NVNO TTM CFF is now -38.35% below its all-time high of $63.96 million, reached on September 30, 2021.
Performance
NVNO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NVNO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | -47.3% | +52.9% |
| 3 y3 years | +71.1% | +100.0% | +100.0% |
| 5 y5 years | +185.6% | +100.0% | +100.0% |
NVNO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -55.2% | -100.0% | -47.3% | >+9999.0% | -31.6% | -100.0% |
| 5 y | 5-year | -55.2% | -100.0% | -64.6% | >+9999.0% | -38.4% | -100.0% |
| alltime | all time | -55.2% | -100.0% | -64.6% | >+9999.0% | -38.4% | -100.0% |
EnVVeno Medical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $13.59 M(>+9900.0%) | $39.43 M(+52.6%) |
| Jun 2024 | - | $0.00(-100.0%) | $25.84 M(0.0%) |
| Mar 2024 | - | $46.00 K(-99.8%) | $25.84 M(+0.2%) |
| Dec 2023 | $25.79 M(>+9900.0%) | $25.79 M(>+9900.0%) | $25.79 M(>+9900.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2022 | $0.00(-100.0%) | - | - |
| Dec 2021 | $57.61 M(+282.1%) | -$4000.00(-100.0%) | $57.61 M(-9.9%) |
| Sep 2021 | - | $19.24 M(>+9900.0%) | $63.96 M(+26.4%) |
| Jun 2021 | - | $0.00(-100.0%) | $50.59 M(-4.3%) |
| Mar 2021 | - | $38.37 M(+504.5%) | $52.87 M(+250.7%) |
| Dec 2020 | $15.07 M | $6.35 M(+8.1%) | $15.07 M(+72.7%) |
| Sep 2020 | - | $5.87 M(+156.9%) | $8.73 M(+205.6%) |
| Jun 2020 | - | $2.29 M(+300.8%) | $2.86 M(-26.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $570.30 K(>+9900.0%) | $3.89 M(-31.0%) |
| Dec 2019 | $5.64 M(-37.6%) | $0.00(0.0%) | $5.64 M(0.0%) |
| Sep 2019 | - | $0.00(-100.0%) | $5.64 M(0.0%) |
| Jun 2019 | - | $3.32 M(+43.3%) | $5.64 M(-40.6%) |
| Mar 2019 | - | $2.32 M(>+9900.0%) | $9.49 M(+5.1%) |
| Dec 2018 | $9.03 M(+122.5%) | $0.00(0.0%) | $9.03 M(-9.7%) |
| Sep 2018 | - | $0.00(-100.0%) | $10.00 M(-12.1%) |
| Jun 2018 | - | $7.17 M(+286.4%) | $11.38 M(+109.4%) |
| Mar 2018 | - | $1.86 M(+91.7%) | $5.44 M(+34.0%) |
| Dec 2017 | $4.06 M(+79.5%) | $968.40 K(-29.9%) | $4.06 M(+31.3%) |
| Sep 2017 | - | $1.38 M(+12.3%) | $3.09 M(+80.8%) |
| Jun 2017 | - | $1.23 M(+156.8%) | $1.71 M(+256.8%) |
| Mar 2017 | - | $478.90 K | $478.90 K |
| Dec 2016 | $2.26 M(-37.6%) | - | - |
| Dec 2015 | $3.62 M | - | - |
FAQ
- What is enVVeno Medical annual cash flow from financing activities?
- What is the all time high annual CFF for enVVeno Medical?
- What is enVVeno Medical annual CFF year-on-year change?
- What is enVVeno Medical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for enVVeno Medical?
- What is enVVeno Medical quarterly CFF year-on-year change?
- What is enVVeno Medical TTM cash flow from financing activities?
- What is the all time high TTM CFF for enVVeno Medical?
- What is enVVeno Medical TTM CFF year-on-year change?
What is enVVeno Medical annual cash flow from financing activities?
The current annual CFF of NVNO is $25.79 M
What is the all time high annual CFF for enVVeno Medical?
enVVeno Medical all-time high annual cash flow from financing activities is $57.61 M
What is enVVeno Medical annual CFF year-on-year change?
Over the past year, NVNO annual cash flow from financing activities has changed by +$25.79 M (+100.00%)
What is enVVeno Medical quarterly cash flow from financing activities?
The current quarterly CFF of NVNO is $13.59 M
What is the all time high quarterly CFF for enVVeno Medical?
enVVeno Medical all-time high quarterly cash flow from financing activities is $38.37 M
What is enVVeno Medical quarterly CFF year-on-year change?
Over the past year, NVNO quarterly cash flow from financing activities has changed by -$12.20 M (-47.30%)
What is enVVeno Medical TTM cash flow from financing activities?
The current TTM CFF of NVNO is $39.43 M
What is the all time high TTM CFF for enVVeno Medical?
enVVeno Medical all-time high TTM cash flow from financing activities is $63.96 M
What is enVVeno Medical TTM CFF year-on-year change?
Over the past year, NVNO TTM cash flow from financing activities has changed by +$13.64 M (+52.88%)